Nordhealth AS initiates share buyback program

Nordhealth AS (the "Company") has decided to initiate a buyback for a maximum consideration of NOK 4 million and for up to 400,000 of its own shares in accordance with the authorization granted to the board of directors by the Company’s annual general meeting held on 24 April 2023.

The share buyback program will be for a maximum consideration of NOK 4 million, and for a maximum of 400,000 shares. The repurchases will be conducted in the period from 5 June 2023 until and including 31 December 2023, or until the maximum number of shares has been repurchased. Buyback transactions will be executed according to the market price on the Oslo Stock Exchange, and the maximum price to be paid per share under the program is NOK 30.

Any shares acquired as part of the buyback program will be used as consideration in future acquisitions by the company, as part the employee share program, or absent of this, be cancelled. Any shares purchased will be held in treasury until used for the above purposes.

The maximum number of shares purchased per day will be 25% of the average daily turnover in the 20 trading days preceding the date of purchase. This limit is in accordance with Market Abuse Regulation (MAR) requirements as described in Article 3 of the EU Commission delegated regulation 2016/1052, and as implemented in Norway under the Securities Trading Act.

For further information, please contact:

Charles Macbain, CEO

charles.macbain@nordhealth.com

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 380 employees working either remotely or from offices (collaboration hubs). Visit the company’s website at nordhealth.com.